BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30190088)

  • 1. Molecular pathogenesis of proliferative verrucous leukoplakia: a systematic review.
    Okoturo EM; Risk JM; Schache AG; Shaw RJ; Boyd MT
    Br J Oral Maxillofac Surg; 2018 Nov; 56(9):780-785. PubMed ID: 30190088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited proliferative oral disorder: a reductionist approach to proliferative verrucous leukoplakia.
    Radhakrishnan R
    Indian J Dent Res; 2011; 22(3):365-6. PubMed ID: 22048571
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.
    Kresty LA; Mallery SR; Knobloch TJ; Li J; Lloyd M; Casto BC; Weghorst CM
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3179-87. PubMed ID: 18990760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferative verrucous leukoplakia. Report of five cases].
    Reichart PA; Philipsen HP
    Mund Kiefer Gesichtschir; 2003 May; 7(3):164-70. PubMed ID: 12764683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell transcriptomics dissects premalignant progression in proliferative verrucous leukoplakia.
    Zhong L; Wang F; Liu D; Kuang W; Ji N; Li J; Zeng X; Li T; Dan H; Chen Q
    Oral Dis; 2024 Mar; 30(2):172-186. PubMed ID: 35950708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.
    Rintala M; Vahlberg T; Salo T; Rautava J
    Head Neck; 2019 May; 41(5):1499-1507. PubMed ID: 30536498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
    Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
    Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative verrucous leukoplakia and field cancerization: report of a case.
    Feller L; Wood NH; Raubenheimer EJ
    J Int Acad Periodontol; 2006 Apr; 8(2):67-70. PubMed ID: 16623182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exploration of tumor suppressors p16INK4a and p14ARF in oral leukoplakias].
    Nitsche M; Koy S; Mörz M; Koch R; Eckelt U
    Mund Kiefer Gesichtschir; 2007 Dec; 11(6):317-26. PubMed ID: 17990010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia.
    Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.
    Müller S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jun; 125(6):591-602. PubMed ID: 29606637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, histopathological characteristics and malignant transformation of proliferative verrucous leukoplakia with 36 patients: a retrospective longitudinal study.
    Zhang C; Lan Q; Wei P; Gao Y; Zhang J; Hua H
    BMC Oral Health; 2024 May; 24(1):639. PubMed ID: 38816724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Management of Proliferative Verrucous Leukoplakia: A Systematic Review of the Literature.
    Abadie WM; Partington EJ; Fowler CB; Schmalbach CE
    Otolaryngol Head Neck Surg; 2015 Oct; 153(4):504-11. PubMed ID: 26044786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially malignant disorders revisited-The lichenoid lesion/proliferative verrucous leukoplakia conundrum.
    Thomson PJ; Goodson ML; Smith DR
    J Oral Pathol Med; 2018 Jul; 47(6):557-565. PubMed ID: 29663518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative verrucous leukoplakia: recognition and differentiation from conventional leukoplakia and mimics.
    Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
    Head Neck; 2014 Nov; 36(11):1662-8. PubMed ID: 24115154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
    Borgna SC; Clarke PT; Schache AG; Lowe D; Ho MW; McCarthy CE; Adair S; Field EA; Field JK; Holt D; Risk JM; Rajlawat BP; Triantafyllou A; Shaw RJ
    Head Neck; 2017 Oct; 39(10):1997-2003. PubMed ID: 28640498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase fraction and DNA ploidy in oral leukoplakia.
    Khanna R; Agarwal A; Khanna S; Basu S; Khanna AK
    ANZ J Surg; 2010; 80(7-8):548-51. PubMed ID: 20795971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative verrucous leukoplakia and its related lesions.
    Batsakis JG; Suarez P; el-Naggar AK
    Oral Oncol; 1999 Jul; 35(4):354-9. PubMed ID: 10645398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
    Gillenwater AM; Vigneswaran N; Fatani H; Saintigny P; El-Naggar AK
    Adv Anat Pathol; 2013 Nov; 20(6):416-23. PubMed ID: 24113312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative verrucous leukoplakia: an aggressive form of oral leukoplakia.
    Shopper TP; Brannon RB; Stalker WH
    J Dent Hyg; 2004; 78(3):7. PubMed ID: 16197744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.